1-11 of 11
Wolfram Klapper
Close
Sort by
Journal Articles

Large B-cell lymphoma- IRF4 + in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?

Clinical Trials & Observations
Minke Huibers, Oussama Abla, Mara Andrés, Olga Balagué, Auke Beishuizen, Elisa Carraro, Alan Chiang, Monika Csóka, Bianca-Andreea David, Maëlle de Ville de Goyet, Gil Gilad, Daiki Hori, Rishi S. Kotecha, Edita Kabickova, Wolfram Klapper, Natasha Miakova, Veronique Minard-Colin, Atsuko Nakazawa, Marta Pillon, Charlotte Rigaud, Itziar Salaverria, Ida Tölle, Jaime Verdú-Amorós, Hannah von Mersi, Wilhelm Wössmann, Birgit Burkhardt, Andishe Attarbaschi
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1509–1514.
https://doi.org/10.1182/bloodadvances.2023012109
Published: 2024
Includes: Supplemental data
Journal Articles

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma

Clinical Trials & Observations
Jakoba J. Eertink, Gerben J. C. Zwezerijnen, Sanne E. Wiegers, Simone Pieplenbosch, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Daphne de Jong, Bauke Ylstra, Matias Mendeville, Ulrich Dührsen, Christine Hanoun, Andreas Hüttmann, Julia Richter, Wolfram Klapper, Yvonne W. S. Jauw, Otto S. Hoekstra, Henrica C. W. de Vet, Ronald Boellaard, Josée M. Zijlstra
Journal: Blood Advances
Blood Adv (2023) 7 (2): 214–223.
https://doi.org/10.1182/bloodadvances.2022008629
Published: 2023
Includes: Supplemental data
Journal Articles

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5482–5493.
https://doi.org/10.1182/bloodadvances.2022008355
Published: 2022
Includes: Supplemental data
Journal Articles

Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma

Clinical Trials & Observations
Diego Villa, Eva Hoster, Olivier Hermine, Wolfram Klapper, Michal Szymczyk, André Bosly, Michael Unterhalt, Lisa M. Rimsza, Colleen A. Ramsower, Ciara L. Freeman, David W. Scott, Alina S. Gerrie, Kerry J. Savage, Laurie H. Sehn, Martin Dreyling
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5285–5294.
https://doi.org/10.1182/bloodadvances.2022007371
Published: 2022
Journal Articles

A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

Julia Salmeron-Villalobos, Caoimhe Egan, Vanessa Borgmann, Inga Müller, Blanca Gonzalez-Farre, Joan Enric Ramis-Zaldivar, Dominik Nann, Olga Balagué, Mónica López-Guerra, Dolors Colomer, Ilske Oschlies, Wolfram Klapper, Selina Glaser, Young Hyeh Ko, Irina Bonzheim, Reiner Siebert, Falko Fend, Stefania Pittaluga, Elias Campo, Itziar Salaverria, Elaine S. Jaffe, Leticia Quintanilla-Martinez
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4661–4674.
https://doi.org/10.1182/bloodadvances.2022007322
Published: 2022
Includes: Supplemental data
Journal Articles

Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma

Niklas Gebauer, Hanno M. Witte, Hartmut Merz, Ilske Oschlies, Wolfram Klapper, Almuth Caliebe, Lars Tharun, Malte Spielmann, Nikolas von Bubnoff, Alfred C. Feller, Eva M. Murga Penas
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5220–5225.
https://doi.org/10.1182/bloodadvances.2021004635
Published: 2021
Includes: Supplemental data
Journal Articles

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

James Peter Stewart, Jana Gazdova, Nikos Darzentas, Dörte Wren, Paula Proszek, Grazia Fazio, Simona Songia, Miguel Alcoceba, Maria Eugenia Sarasquete, Patrick Villarese, Michèle Y. van der Klift, Kim C. Heezen, Neil McCafferty, Karol Pal, Mark Catherwood, Chang Sik Kim, Shambhavi Srivastava, Leonie I. Kroeze, Elizabeth Hodges, Kostas Stamatopoulos, Wolfram Klapper, Elisa Genuardi, Simone Ferrero, Michiel van den Brand, Giovanni Cazzaniga, Frederic Davi, Lesley-Ann Sutton, Ramon Garcia-Sanz, Patricia J. T. A. Groenen, Elizabeth A. Macintyre, Monika Brüggemann, Christiane Pott, Anton W. Langerak, David Gonzalez, on behalf of the EuroClonality-NGS Working Group
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3188–3198.
https://doi.org/10.1182/bloodadvances.2020004056
Published: 2021
Includes: Supplemental data
Journal Articles

Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma

Clinical Trials & Observations
Jonathan C. Strefford, Malgorzata Nowicka, Chantal E. Hargreaves, Cathy Burton, Andrew Davies, Rosalind Ganderton, Wolfgang Hiddemann, Chisako Iriyama, Wolfram Klapper, Kate V. Latham, Maurizio Martelli, Farheen Mir, Helen Parker, Kathleen N. Potter, Matthew J. J. Rose-Zerilli, Laurie H. Sehn, Marek Trněný, Umberto Vitolo, Christopher R. Bolen, Christian Klein, Andrea Knapp, Mikkel Z. Oestergaard, Mark S. Cragg
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2935–2944.
https://doi.org/10.1182/bloodadvances.2020003985
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Clinical Trials & Observations
Malgorzata Nowicka, Laura K. Hilton, Margaret Ashton-Key, Chantal E. Hargreaves, Chern Lee, Russell Foxall, Matthew J. Carter, Stephen A. Beers, Kathleen N. Potter, Christopher R. Bolen, Christian Klein, Andrea Knapp, Farheen Mir, Matthew Rose-Zerilli, Cathy Burton, Wolfram Klapper, David W. Scott, Laurie H. Sehn, Umberto Vitolo, Maurizio Martelli, Marek Trneny, Christopher K. Rushton, Graham W. Slack, Pedro Farinha, Jonathan C. Strefford, Mikkel Z. Oestergaard, Ryan D. Morin, Mark S. Cragg
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2945–2957.
https://doi.org/10.1182/bloodadvances.2021004770
Published: 2021
Includes: Supplemental data
Journal Articles

Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

Clinical Trials & Observations
Stefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, Sarah Haebe, Verena Passerini, Johannes C. Hellmuth, Erik Gaitzsch, William Keay, Natyra Tahiri, Anna Zoellner, Andreas Rosenwald, Wolfram Klapper, Harald Stein, Alfred Feller, German Ott, Annette M. Staiger, Heike Horn, Martin L. Hansmann, Christiane Pott, Michael Unterhalt, Christian Schmidt, Martin Dreyling, Ash A. Alizadeh, Wolfgang Hiddemann, Eva Hoster, Oliver Weigert
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4451–4462.
https://doi.org/10.1182/bloodadvances.2020002546
Published: 2020
Includes: Supplemental data
Journal Articles

A B-cell–associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology

Thomas Yssing Michaelsen, Julia Richter, Rasmus Froberg Brøndum, Wolfram Klapper, Hans Erik Johnsen, Mads Albertsen, Karen Dybkær, Martin Bøgsted
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1542–1546.
https://doi.org/10.1182/bloodadvances.2018017988
Published: 2018
Includes: Supplemental data